2,2,2-Trifluoro-N-(3-iodophenyl)acetamide

Catalog No.: 
ACPDCX994
CAS No.: 
180530-11-4
Molecular Formula: 
C8H5F3INO
Molecular Weight: 
315.03
2,2,2-Trifluoro-N-(3-iodophenyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%
100mg95%
250mg95%
1g95%
5g95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,2,2-Trifluoro-N-(3-iodophenyl)acetamide
IUPAC Name2,2,2-trifluoro-N-(3-iodophenyl)acetamide
MDL No.MFCD07535092
Molecular FormulaC8H5F3INO
Molecular Weight315.03
SMILESO=C(NC1=CC=CC(I)=C1)C(F)(F)F
InChI KeyZEWYVZSMKUUMNZ-UHFFFAOYSA-N
SynonymAcetaMide, 2,2,2-trifluoro-N-(3-iodophenyl)-;2,2,2-trifluoro-N-(3-iodophenyl)acetamide
CAS No.180530-11-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACPDCX994 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBAUS147 route compound structure diagram
    ACBAUS1472923-16-2In Stock
  4. Then
  5. ACPDCX994 route product structure diagram
    ACPDCX994180530-11-4
Inquiry

2. ACPDCX994 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPDCX994 route product structure diagram
    ACPDCX994180530-11-4
Inquiry

3. ACPDCX994 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPDCX994 route product structure diagram
    ACPDCX994180530-11-4
Inquiry

Comments (0)